(NRSN) Neurosense - Performance -11.1% in 12m
Compare NRSN with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-50.87%
#77 in Group
Rel. Strength
27.25%
#5789 in Universe
Total Return 12m
-11.08%
#63 in Group
Total Return 5y
-74.16%
#86 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -49.02%
(?) Percentile in Group
12m Total Return: NRSN (-11.1%) vs XBI (-14%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: NRSN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NRSN
Total Return (including Dividends) | NRSN | XBI | S&P 500 |
---|---|---|---|
1 Month | 9.87% | 2.02% | 2.87% |
3 Months | -7.63% | -15.44% | -6.42% |
12 Months | -11.08% | -14.02% | 9.87% |
5 Years | -74.16% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | NRSN | XBI | S&P 500 |
1 Month | -1.20% | 57% | 89.4% |
3 Months | -71.7% | -82.3% | -72% |
12 Months | 4.80% | -53.1% | 49.3% |
5 Years | -69.6% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #73 | 7.70% | 6.81% |
3 Month | #85 | 9.23% | -1.29% |
12 Month | #63 | 3.43% | -19.1% |
5 Years | #78 | -62.3% | -79.7% |
FAQs
Does NRSN Neurosense outperforms the market?
Yes,
over the last 12 months NRSN made -11.08%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months NRSN made -7.63%, while XBI made -15.44%.
Over the last 3 months NRSN made -7.63%, while XBI made -15.44%.
Performance Comparison NRSN vs Indeces and Sectors
NRSN vs. Indices NRSN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 1.77% | 7.00% | -15.8% | -21.0% |
US NASDAQ 100 | QQQ | 1.52% | 5.16% | -16.2% | -22.4% |
US Dow Jones Industrial 30 | DIA | 1.49% | 8.26% | -14.7% | -17.5% |
German DAX 40 | DAX | -0.35% | -9.41% | -41.4% | -36.2% |
Shanghai Shenzhen CSI 300 | CSI 300 | 1.11% | 3.60% | -15.0% | -16.7% |
Hongkong Hang Seng | HSI | -1.75% | -6.34% | -25.3% | -23.2% |
India NIFTY 50 | INDA | 4.16% | 7.59% | -17.7% | -13.4% |
Brasil Bovespa | EWZ | -0.28% | -1.66% | -25.0% | -4.60% |
NRSN vs. Sectors NRSN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 1.59% | 6.20% | -22.0% | -31.4% |
Consumer Discretionary | XLY | 0.85% | 6.36% | -13.6% | -25.1% |
Consumer Staples | XLP | 2.14% | 7.85% | -22.7% | -18.6% |
Energy | XLE | 0.79% | 9.79% | -9.77% | -1.32% |
Financial | XLF | 1.14% | 4.30% | -21.7% | -32.6% |
Health Care | XLV | 5.56% | 14.3% | -10.5% | -5.16% |
Industrial | XLI | 0.20% | 2.49% | -16.8% | -21.1% |
Materials | XLB | 1.78% | 5.16% | -11.7% | -5.05% |
Real Estate | XLRE | 2.10% | 3.75% | -18.2% | -24.5% |
Technology | XLK | 0.88% | 3.13% | -13.5% | -18.1% |
Utilities | XLU | 0.73% | 4.25% | -23.5% | -27.0% |
Aerospace & Defense | XAR | 1.26% | 0.53% | -25.1% | -36.2% |
Biotech | XBI | 9.85% | 7.85% | 5.29% | 2.94% |
Homebuilder | XHB | 2.21% | 6.80% | -2.14% | -1.33% |
Retail | XRT | 1.62% | 6.28% | -9.48% | -6.76% |